DOCSLIB.ORG

Belgian Journal of Paediatrics

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Belgian Journal of Paediatrics B P Belgian Journal BELGISCHE VERENIGING of Paediatrics VOOR KINDERGENEESKUNDE J SOCIÉTÉ BELGE DE PÉDIATRIE Publication of the Belgian Society of Paediatrics 2020 - Volume 22 - number 4 - December Theme: Obesity Causes and consequences of childhood obesity Genetic forms of obesity Developmental exposure to Bisphenol A : a contributing factor to the increased incidence of obesity ? The interactions between obesity and sleep What about our vulnerable children in the multidisciplinary approach of childhood obesity or overweight? Prenatal, natal and postnatal determinants of childhood obesity A heavy question: how do we approach children with overweight or obesity in 2020? Interdisciplinary overweight outpatient management in pediatrics Inpatient treatment of children and adolescents with severe obesity Physical determinants of weight loss during a residential rehabilitation program for adolescents with obesity Bariatric surgery in adolescents: information for the general pediatrician Articles Recurrent acute event in an infant Progressive pneumonia with pleural effusion and pneumomediastinum as presenting symptom of a hypopharyngeal perforation in a one year old boy Survey about the alcohol consumption by minors in Flemish youth movements Management of arteriovenous malformations in pediatric population: about two cases A rare presentation of congenital spinal dermal sinus Some trainees are more equal than others - The paediatric residency payment gap, as illustrated in a cross-sectional study in Flanders Umbilical Venous Catheter-Related Complications: A Retrospective Study at the University Hospital of Leuven Made in Belgium Unravelling the genetic cause of life-threatening infections in children Paediatric Cochrane Corner Systemic treatments for eczema Belgische Vereniging voor Kindergeneeskunde Société Belge de Pédiatrie QUARTERLY V.U./E.R. S. C. Chantrain (ULB), M. Raes (KUL) ISSN 2466-8907 (printed version) UZ Leuven, Herestraat 49, 3000 Leuven ISSN 2566-1558 (digital version) E-mail: [email protected] Editorial Board Founding editors Universities Associations L. Corbeel, W. Proesmans G. Buyse (UZ Leuven), MC Seghaye (ULG), A. Bael (VVK) Chief Editors P. Smeesters (ULB), S. Van Daele (UZ Gent) P. Philippet (GBPF) Y. Vandenplas (VUB), S. Moniotte (UCL), S. Verhulst (UZA) C. Chantrain, M. Raes Belgian Academy of Paediatrics ® Associate Editors BVK-SBP Executive Committee A. De Guchtenaere, President NUTRILON PROFUTURA C. Barrea, S. Cadranel, O. Danhaive, M. Raes, President S. Moniotte, vice-president I. Decuyper, S. De Rechter, N. Francotte, F. Smets, Vice-president T. Jonckheer, Secretary ONZE MEEST GEAVANCEERDE FORMULE L. Hoste, L. Panneel, A. Rochtus, Y. Vandenplas, G. Buyse, Secretary P. Philippet, treasurer K. van Hoeve, A. Vuckovic, M. Wojciechowski P. Smeesters, Secretary VOOR DE OVERGANG VAN BORST- NAAR FLESVOEDING D. Dewolf, Treasurer Secretariat A. Malfroot, Past-president OF IN COMBINATIE MET BORSTVOEDING N. Meignen D. Van Gysel, International societies Contents • Editorial 201 • Obituary for Samy Cadranel 202 • Save The Date 203 • In Memoriam 204 HMO’s • Theme: Obesity Onze hoogste hoeveelheid HMO’s Editorial (Human Milk Oligosaccharides) J. Vinckx, M.-C. Lebrethon 209 Causes and consequences of childhood obesity 120 E. Rijckmans, K. Van De Maele, I. Gies 210 JAAR Genetic forms of obesity NUTRICIA V. Beauloye, I. Gies, M. Barea, M. Lannoo, R. Devlieger, E. Dirinck, B. Lembo, D. Vissers, A. Verrijken, J.-P. Thissen, ONDERZOEK ß-PALMITAAT B. Van Der Schueren 214 UIT MELKVETTEN Developmental exposure to Bisphenol A : a contributing factor to the increased incidence of obesity? J. Fudvoye, M.-C. Lebrethon, A.-S. Parent 220 The interactions between obesity and sleep PREBIOTICA K. Van Hoorenbeeck 224 scGOS:lcFOS (9:1) What about our vulnerable children in the multidisciplinary approach of childhood obesity or overweight? N. Baeck, E. Moens, R. Jeannin 226 Prenatal, natal and postnatal determinants of childhood obesity G. Massa 228 POSTBIOTICA A heavy question: how do we approach children with overweight or obesity in 2020? R. Jeannin, S. De Groote, K. Van Hoeck, A. Vandeputte, J. Toelen 234 Interdisciplinary overweight outpatient management in pediatrics OMEGA 3 & 6 S. Moline, J. Fudvoye, A.-S. Parent, C. Waxweiler, A.-C. Dewandre, C. Lagasse, M.-C. Seghaye, M.-C. Lebrethon 240 Inpatient treatment of children and adolescents with severe obesity A. Tanghe, T. Fondelli, M. Van Helvoirt, L. Van Roye, J. Blanckaert, N. Marlein, E. Dupont 244 Physical determinants of weight loss during a residential rehabilitation program for adolescents with obesity G. Mets, G. Marissens, J. Servayge, K. Vandekerckhove, B. Wurth, A. De Guchtenaere 250 Bariatric surgery in adolescents: information for the general pediatrician H. Reusens, K. Leonard, M. Moretti, A. Descamps, L. Wauthier, A.-C. Morere, H. Steyaert 254 • Articles Recurrent acute event in an infant E. Pizzuti, N. Genis, P. Perlot, P. Smeesters, S. Rooze 261 Progressive pneumonia with pleural effusion and pneumomediastinum as presenting symptom of a hypopharyngeal perforation in a one year old boy. A. Heyndrickx, L. Matthyssens, K. Van Renterghem, A. Verrijckt, K. Bonte, R. De Bruyne, M. Van Winckel, S. Vande Velde, S. Van Biervliet 264 Survey about the alcohol consumption by minors in Flemish youth movements ONZE MEEST GEAVANCEERDE M. Papy, J. Toelen 268 FORMULE UIT ONDERZOEK Management of arteriovenous malformations in pediatric population: about two cases A. Remy, J.-J. Kengo, M. Rodesch, M. Maka, B. Lubicz, B. Mine 272 GEÏNSPIREERD OP MOEDERMELK A rare presentation of congenital spinal dermal sinus Geïnspireerd door borst voeding, ontwikkelen de teams D. Blommaert, W. van Herk, R. de Jong, J. Spoor, S. Hammer, S. de Man 274 Some trainees are more equal than others - The paediatric residency payment gap, as illustrated in a van wetenschappers, kinderartsen en voedingskundigen cross-sectional study in Flanders bij Nutricia de meest geavanceerde Nutrilon® formules. L. Hoste, S. Daelemans, L. Dossche, A. De Guchtenaere, A. Bael 278 Nutrilon® Profutura, met ons hoogste gehalte aan HMO´s, Umbilical Venous Catheter-Related Complications: A Retrospective Study at the University Hospital of Leuven E. Exelmans, S. Van Lierde, V. Cossey 282 is speciaal ontworpen voor de overgang naar fl es voeding • Made in Belgium of in combinatie met borstvoeding. Unravelling the genetic cause of life-threatening infections in children G. Bucciol 286 Belangrijk: Borstvoeding is de ideale voeding voor baby’s. Deze informatie is uitsluitend bestemd voor (para)medici. • Paediatric Cochrane Corner V.U.: N.V. Nutricia België – Werkhuizenkaai 160 – 1000 Brussel – 12/2020 Systemic treatments for eczema A. C. Vanhove, T. Bekkering, F. Cools 290 • Editorial Policy 292 199 20-17875 Nut HCP - Profutura insert Percentiel - A4 NL v02.indd 1 16/11/2020 15:42 Editorial Dear colleagues, 2020 has been a very special year and we hope that 2021 will bring us to better horizons. In our editorial of September, we announced that Prof. Samy Cadranel had decided to retire from his role as editor-in-chief of the Belgian Journal of Paediatrics. Together with the entire editorial board we paid tribute to his creativity, his intelligence, his diplomacy and his joviality. On October 8th 2020, before the September edition arrived in your mailboxes, we learned that Professor Cadranel passed away. In addition to an outstanding editor-in-chief, we lose a passionate paediatrician and a friend. Thank you Samy for everything you gave to the journal and to our group. One more time, we express our deep sorrow to Mrs Cadranel and Samy's family. In this issue we publish an In Memoriam on behalf of the board of the BVK/SBP and an Obituary on behalf of the ESPGHAN family. The corona-virus vaccine is knocking on our door. Paediatricians have always been major players in vaccination. Although children have less risk of severe COVID-19 forms and will probably be included later in the vaccination program, we are convinced that pediatricians will play an important role in reassuring and informing parents and families. We hope that the progressive campaign in Belgium and all around the world will help us to return to normal life and to reexperience the joy of being together, with family, friends and colleagues. In this Holiday Season and before a new (we hope, an ultimate) effort, this is our wish for all of us. The core content of the BJP issue is devoted to the theme “ Obesity in childhood”. It was coordinated by Joseph Vinckx (KULeuven) and Marie-Christine Lebrethon (ULg). We thank our guest editors for their very dedicated commitment and all the authors for their remarkable contributions. The causes and consequences of this pathology are reviewed with a particular focus on genetic forms, exposure to bisphenol A and pre and postnatal determinants. The therapeutic approaches of obesity are also discussed. The specificities of inpatient, outpatient as well as bariatric surgery in children are detailed by our Belgian experts . As suggested on our cover designated exclusively by Serge Ernst for the journal, we are sure you will enjoy it ! In addition to these theme articles, we are also pleased to publish clinical cases that were reported by young colleagues in training: recurrent acute event in an infant, hypopharyngeal perforation presenting as progressive pneumonia and pneumomediastinum and rare presentation of congenital spinal dermal sinus. Larger series or studies are also published in this issue. A survey analyses the alcohol consumption
Load more

Recommended publications
  • Press Release Stockholm, September 16, 2020
    PRESS RELEASE STOCKHOLM, SEPTEMBER 16, 2020 Cutting-edge cancer treatment comes to Belgium with the installation of RayCare and RayStation at Particle Therapy Interuniversity Centre Leuven Advanced treatment planning system (TPS) RayStation®* and next-generation oncology information system (OIS) RayCare®* are now in operation at the brand new Particle Therapy Interuniversity Centre Leuven (PARTICLE). The center is the first proton therapy clinic in the world with the combination of RayCare and IBA’s single-room proton therapy device Proteus®ONE. Part of an interuniversity project of University Hospitals Leuven (together with KU Leuven and Cliniques universitaires Saint-Luc-UCLouvain and supported by UZ Gent, CHU UCL Namur, UZ Brussel and UZA), PARTICLE has been created to offer clinical care, in addition to education, training and research and development. The collaborative center has partnered with leading academic partners and research institutes, as well as with industrial partners such as RaySearch, supplier of RayCare and RayStation, and IBA, the supplier of the proton therapy device ProteusONE. RayCare is designed to enable clinicians to fluidly coordinate tasks and ensure optimal use of resources. PARTICLE is the first proton therapy center in the world to install RayCare to support comprehensive cancer care and treatment delivery in combination with ProteusONE, a compact proton beam therapy device featuring the latest generation pencil beam scanning and isocenter volumetric imaging capabilities. Together, the advanced software from RaySearch and cutting-edge equipment from IBA will position PARTICLE at the forefront of innovative cancer treatment in Belgium. The combination of the technologies will help patients in the country gain critical access to proton therapy, which is the optimal option for cancer patients where treatment options are limited, or where conventional radiotherapy presents an unacceptable risk to the patient – as is often the case with children.
    [Show full text]
  • Premiers Patients Traités Au Centre De Protonthérapie À Louvain
    Premiers patients traités au centre de protonthérapie à Louvain PARTICLE, le premier centre de protonthérapie belge est mis en service Mercredi 16 septembre 2020 — Pendant l'été 2020, les premiers patients ont pu être accueillis et ont bénéficié d’une protonthérapie dans le nouveau centre de protonthérapie implanté sur le campus “Gasthuisberg” de l’UZ Leuven (Louvain) et exploité conjointement par des équipes d’UZ Leuven et des Cliniques universitaires Saint-Luc. La protonthérapie est une forme innovante de radiothérapie qui permet de traiter une tumeur de manière très ciblée et, ainsi, d’endommager le moins possible les tissus sains environnants. C’est la première fois que des traitements par protonthérapie sont administrés en Belgique. Le traitement des premiers patients s'est bien déroulé. C’est en automne 2016 qu’a débuté la construction de PARTICLE, le premier centre de protonthérapie en Belgique. Cet été, PARTICLE est entré en fonction à Louvain. Le premier patient, un jeune homme présentant une tumeur rare au cerveau, a été pris en charge le 22 juillet 2020. Depuis, 7 patients ont déjà pu bénéficier d’un traitement par protonthérapie. La protonthérapie est une forme innovante de radiothérapie qui permet de traiter une tumeur maligne de manière très ciblée et qui, de ce fait, endommage moins les tissus sains. Cette thérapie est en plein essor dans le monde entier pour le traitement de patients nécessitant une protection spécifique des tissus environnants. Il peut s’agir d’enfants atteints d'un cancer ou d’adultes avec une tumeur située à proximité d'un organe vital ou sensible comme les yeux ou le cerveau.
    [Show full text]
  • A Guide to Obesity and the Metabolic Syndrome
    A GUIDE TO OBESITY AND THE METABOLIC SYNDROME ORIGINS AND TREAT MENT GEORG E A. BRA Y Louisiana State University, Baton Rouge, USA Boca Raton London New York CRC Press is an imprint of the Taylor & Francis Group, an informa business © 2011 by Taylor and Francis Group, LLC CRC Press Taylor & Francis Group 6000 Broken Sound Parkway NW, Suite 300 Boca Raton, FL 33487-2742 © 2011 by Taylor and Francis Group, LLC CRC Press is an imprint of Taylor & Francis Group, an Informa business No claim to original U.S. Government works Printed in the United States of America on acid-free paper 10 9 8 7 6 5 4 3 2 1 International Standard Book Number: 978-1-4398-1457-4 (Hardback) This book contains information obtained from authentic and highly regarded sources. Reasonable efforts have been made to publish reliable data and information, but the author and publisher cannot assume responsibility for the valid- ity of all materials or the consequences of their use. The authors and publishers have attempted to trace the copyright holders of all material reproduced in this publication and apologize to copyright holders if permission to publish in this form has not been obtained. If any copyright material has not been acknowledged please write and let us know so we may rectify in any future reprint. Except as permitted under U.S. Copyright Law, no part of this book may be reprinted, reproduced, transmitted, or uti- lized in any form by any electronic, mechanical, or other means, now known or hereafter invented, including photocopy- ing, microfilming, and recording, or in any information storage or retrieval system, without written permission from the publishers.
    [Show full text]
  • The Encyclopedia of Endocrine Diseases and Disorders
    THE ENCYCLOPEDIA OF lJ z > 0 z Endocrine < I ~ Diseases UJ< I and Disorders UJ ...J '-'- z 0 V'l 1- u '-'-< WILLIAM P ETIT. JR.. M.0. CHRISTINE ADAMEC THE ENCYCLOPEDIA OF ENDOCRINE DISEASES AND DISORDERS THE ENCYCLOPEDIA OF ENDOCRINE DISEASES AND DISORDERS William Petit Jr., M.D. Christine Adamec The Encyclopedia of Endocrine Diseases and Disorders Copyright © 2005 by William Petit Jr., M.D., and Christine Adamec All rights reserved. No part of this book may be reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, or by any information storage or retrieval systems, without permission in writing from the publisher. For information contact: Facts On File, Inc. 132 West 31st Street New York NY 10001 Library of Congress Cataloging-in-Publication Data Petit, William. The encyclopedia of endocrine diseases and disorders / William Petit Jr., Christine Adamec. p. ; cm. Includes bibliographical references and index. ISBN 0-8160-5135-6 (hc : alk. paper) 1. Endocrine glands—Diseases—Encyclopedias. [DNLM: 1. Endocrine Diseases—Encyclopedias—English. WK 13 P489ea 2005] I. Adamec, Christine A., 1949– II. Title. RC649.P48 2005 616.4’003—dc22 2004004916 Facts On File books are available at special discounts when purchased in bulk quantities for businesses, associations, institutions, or sales promotions. Please call our Special Sales Department in New York at (212) 967-8800 or (800) 322-8755. You can find Facts On File on the World Wide Web at http://www.factsonfile.com. Text and cover design by Cathy Rincon Printed in the United States of America VB FOF 10 9 8 7 6 5 4 3 2 1 This book is printed on acid-free paper.
    [Show full text]
  • Cancers of the Oesophagus Preferred Model of Care and Criteria for Reference Centres
    CANCERS OF THE OESOPHAGUS PREFERRED MODEL OF CARE AND CRITERIA FOR REFERENCE CENTRES Coordinators: Toni Lerut (Surgery, UZ Leuven) and Philippe Nafteux (Surgery, UZ Leuven) Authors : Toni Lerut (Surgery, UZ Leuven), Philippe Nafteux (Surgery, UZ Leuven), Tom Boterberg (Radiation oncology, Universiteit Gent), Paul Leyman (Surgery, GZA), Donald Claeys (Surgery, AZ Maria Middelares Gent), Jean-Marie Collard (Surgery, UCL), Claude Cuvelier (Pathology, UZ Gent), Pieter Demetter (Pathology, Hôpital Erasme), Pierre Deprez (Gastroenterology, UCL), Dirk De Vriendt (Surgery, AZ Groeninge), Karin Haustermans (Radiation oncology, UZ Leuven), Anne Jouret-Mourin (Pathology, UCL), Jan Lesaffer (Surgery, AZ Sint-Jan Brugge), Piet Pattyn (Gastrointestinal Surgery, Universiteit Gent), Marc Peeters (Gastroenterology, UZA), Hans Prenen (Digestive oncology, UZ Leuven), Xavier Sagaert (Pathology, UZ Leuven), Daniel Van Daele (Gastroenterology, CHU Liège), Tom Van der Vurst (Surgery, CHR Namur), Jean-Luc Van Laethem (Gastroenterology, ULB), Yves Van Molhem (Surgery, OLVZ Aalst), Joseph M. Weerts (Surgery, CHC Liège) Reviewers : M. Fontaine (Physiotherapist, UZ Leuven); S. Wouters (Dietician, UZ Leuven); E. Vos (Social Worker, UZ Leuven); K. Luyten (Onconurse, Radiation Oncology, UZ Leuven); H. Waelkens (Psychologist, UZ Leuven); S. De Keersmaecker (Onconurse, Digestive oncology, UZ Antwerp); J. Moons (Database manager and Nurse surgery, UZ Leuven); H. Vandeweeghe (Head Nurse, Departement Thoracic Surgery, UZ Leuven). Disclaimer : The coordinators of the working groups and all the authors listed by chapter have worked autonomously under the supervision of the KCE team. The KCE experts are not co-authors of these proposals and did not necessarily validate their content. Hospitals with which coordinators and authors of these proposals are affiliated are not de facto considered Reference Centres.
    [Show full text]
  • Poster Presentations
    ______________________________________ P1-d1-164 Adrenals and HPA Axis 1 Arterial hypertension in children: alterations in mineralocorticoid and glucocorticoid axis and their impact on pro-inflammatory, endothelial damage, and oxidative stress parameters Carmen Campino1; Rodrigo Bancalari2; Alejandro Martinez-Aguayo2; Poster Presentations Marlene Aglony2; Hernan Garcia2; Carolina Avalos2; Lilian Bolte2; Carolina Loureiro2; Cristian Carvajal1; Lorena Garcia3; Sergio Lavanderos3; Carlos Fardella1 1Pontificia Universidad Catolica, Endocrinology, and Millennium Institute of Immunology and Immunotherapy, Santiago, Chile; 2Pontificia Universidad Catolica, pediatrics, Santiago, Chile; 3Universidad de Chile, School of Chemical Sciences, Santiago, Chile Background and aims: The pathogenesis of arterial hypertension and its impact and determining factors with respect to cardiovascular damage in chil- dren is poorly understood. We evaluated the prevalence of alterations in the mineralocorticoid and glucocorticoid axes and their impact on pro-inflam- matory, endothelial damage and oxidative stress parameters in hypertensive children. Methods: 306 children (5-16 years old); Group 1: Hypertensives (n=111); Group 2: normotensives with hypertensive parents (n=101); Group 3: normotensives with normotensives parents (n= 95). Fasting blood samples were drawn for hormone measurements (aldosterone, plasma renin activity (PRA), cortisol (F), cortisone (E)); inflammation vari- ______________________________________ ables (hsRCP, adiponectin, IL-6, IL-8, TNF-α); endothelial damage (PAI-I, P1-d1-163 Adrenals and HPA Axis 1 MMP9 and MMP2 activities) and oxidative stress (malondialdehyde). Famil- The role of S-palmitoylation of human ial hyperaldosteronism type 1 (FH-1) was diagnosed when aldosterone/PRA ratio >10 was associated with the chimeric CYP11B1/CYP11B2 gene. The glucocorticoid receptor in mediating the non- 11β-HSD2 activity was considered altered when the F/E ratio exceeded the genomic actions of glucocorticoids mean + 2 SD with respect to group 3.
    [Show full text]
  • Doctor and Pharmacist, Hand in Glove? Report After a Year of Clinical Internship in Belgium
    L Leemans1, L Willems2, R Kinget 1, N Verbeke1, A Verbruggen1, D Knockaert2, G Laekeman1 1Faculty of Pharmaceutical Sciences, KU Leuven; 2UZ Leuven, Belgium DOCTOR AND PHARMACIST, HAND IN GLOVE? REPORT AFTER A YEAR OF CLINICAL INTERNSHIP IN BELGIUM At the dawn of the 21st century, doctors and pharmacists appear to be seeking more and more contact with each other. The main motives appear to be in the area of pharmacotherapy. This paper provides a general review of the history of collaboration between physicians and pharmacists, focusing especially on cooperation with hospital pharmacies. It also describes the clinical internship, during which final-year students in pharmacy are offered 2 months’ training in various hospital departments. In the academic year 1998–9, after a strict selection process, 12 students followed the training and seven departments were explored: endocrinology, g a s t ro e n t e ro l o g y, internal medicine, oncology, paediatrics, pneumology and emerg e n c y medicine. By means of this interdisciplinary method of education, the KU Leuven is striving for a practically oriented training, that a student must study to guarantee adequate provision of care in the 21 st century. KEY WORDS: Belgium, collaboration, doctors, education, pharmaceutical care, pharmacists HISTORICAL RELATIONSHIPS to have frequent conversations. The topics discussed Those who believe that collaboration between doctor and were mainly therapeutic matters (usually regarding new pharmacist is a brand new development in the framework drugs and drug interactions), the method of prescription of our profession are wrong. These professions have (both regarding specialties and individually prescribed a p p e a red to be naturally linked to each other for preparations) and repayment stipulations [2].
    [Show full text]
  • Obituary Prof. Dr. Ruth Illig
    International Journal of Neonatal Screening Obituary Obituary Prof. Dr. Ruth Illig Annette Grüters-Kieslich 1,*, Toni Torresani 2 and Daniel Konrad 3 1 Chief Medical Director and Chairwoman of the Board, Heidelberg University Hospital, Im Neuenheimer Feld 672, 69120 Heidelberg, Germany 2 Former Director Swiss Newborn Screening Laboratory, University Children‘s Hospital, Steinwiesstrasse 75, 8032 Zürich, Switzerland; [email protected] 3 Head of the Department of Paediatric Endocrinology and Diabetology, University Children‘s Hospital, Steinwiesstrasse 75, 8032 Zürich, Switzerland; [email protected] * Correspondence: [email protected] Received: 27 July 2017; Accepted: 28 July 2017; Published: 3 August 2017 On 26 June 2017 Prof. Dr. Ruth Illig peacefully passed away after a life fulfilled with an untiring commitment for children with endocrine diseases. She has been an enthusiastic fighter for the improvement of child health not only in Europe, but also with a global perspective. Ruth Illig was born on 12 November 1924 in Nuremberg, Germany. Her childhood and adolescence in Germany was affected by the Second World War. During the war, she was brought from Germany to Switzerland to recover from the stressful situation and physical weakening. After the war, she spent a significant time of her academic training in Bern and Zurich. Following graduation from medical school she was accepted by Prof. Guido Fanconi for a pediatric residency at the University Children’s Hospital (Kinderspital) Zurich, Switzerland. She was promoted to a fellow and tenure position and worked closely with Prof. Andrea Prader. In these early years, she focused on growth disorders and she established the endocrine laboratory using radioimmunoassays for determination of growth hormone and insulin.
    [Show full text]
  • A Pooled Analysis of Overall Survival in COMFORT-I and COMFORT-II, 2 Randomized Phase III Trials of Ruxolitinib for the Treatment of Myelofibrosis
    Myeloproliferative Disorders SUPPLEMENTARY APPENDIX A pooled analysis of overall survival in COMFORT-I and COMFORT-II, 2 randomized phase III trials of ruxolitinib for the treatment of myelofibrosis Alessandro M. Vannucchi, 1 Hagop M. Kantarjian, 2 Jean-Jacques Kiladjian, 3 Jason Gotlib, 4 Francisco Cervantes, 5 Ruben A. Mesa, 6 Nicholas J. Sarlis, 7 Wei Peng, 7 Victor Sandor, 7 Prashanth Gopalakrishna, 8 Abdel Hmissi, 8 Viktoriya Stalbovskaya, 8 Vikas Gupta, 9 Claire Harrison, 10 and Srdan Verstovsek 2 on behalf of the COMFORT Investiga - tors a 1University of Florence, Italy; 2The University of Texas MD Anderson Cancer Center, Houston, TX, USA; 3Hôpital Saint-Louis et Université Paris Diderot, Paris, France; 4Stanford Cancer Institute, CA, USA; 5Hospital Clínic, Institut d’Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain; 6Mayo Clinic, Scottsdale, AZ, USA; 7Incyte Corporation, Wilmington, DE, USA; 8Novartis Pharma AG, Basel, Switzerland; 9Princess Margaret Cancer Center, University of Toronto, Ontario, Canada; and 10 Guy’s and St. Thomas’ NHS Foundation Trust, Guy’s Hospital, London, UK ©2015 Ferrata Storti Foundation. This is an open-access paper. doi:10.3324/haematol.2014.119545 Manuscript received on October 28, 2014. Manuscript accepted on June 5, 2015. Correspondence: [email protected] Supplemental Materials COMFORT-I Investigators Australia: Royal Perth Hospital, Perth, WA – P. Cannell; Peninsula Haematology and Oncology Clinic, Frankston Hospital, Frankston, Victoria – J. V. Catalano; St. George Hospital, Kogarah, NSW – B. H. Chong; Monash University/Box Hill Hospital, Box Hill, Victoria – P. Coughlin; Royal Brisbane and Women’s Hospital, Herston, Queensland – S. T. S. Durrant; Monash Medical Centre, Clayton, Victoria – T.
    [Show full text]
  • Pediatric Endocrinology
    Books & journals books Adrenal: Fluck, C. E. (ed.) & Miler, W. L. (ed.) . Disorders of the human adrenal cortex. Basel: Karger; 2018. Krieger, D. T. Cushing's syndrome. Berlin: Springer; 1982. Lajic, Svetlana . Molecular analysis of mutated P450c21 in congenital adrenal hyperplasia. Stockholm: Department of Women and Child Health Pediatr; 1998. Lehnert, Hendrik (ed.) . Pheochromocytoma; pathophysiology and clinical management. Basel: Karger; 2004. New, Maria . Advances in steroid disorders in children. Parma: Universita' Degli Studi di Parma; 2000. New, Maria I. (ed.) & Levine, Lenore S. (ed.) . Adrenal diseases in childhood. Basel: Karger; 1984. Vinson, G. P. (ed.) & Anderson, D. C. (ed.) . Adrenal glands, vascular system and hypertension. Bristol: Journal of Endocrinology; 1996. Aging: Brunner,D Jokl, E Eds. Physical activity and aging Basel: Karger,S; 1970. Corpas, Emiliano (ed.) . Endocrinology of Aging ; clinical aspects in diagrams and images. Amsterdam: Elsevier; 2021. Morrison, Mary F. (ed.) . Hormones, gender and the aging brain ; the endocrine basis of geriatric psychiatry. Cambridge: Cambridge University Press; 2000. Olshansky, S. Jay & Carnes, Bruce A. The Quest for immortality ; science at the frontiers of aging. New York: W. W. Norton & Company; 2001. Sinnott, Jan D. Sex roles and Aging : theory and research from a systems perspective. Basel: Karger; 1986. Werner Kohler, Jena (ed.) . Altern und lebenszeit ; vortrage anlablich der jahresversammlung vom 26. bis 29. ; marz 1999 zu halle (saale). Halle: Deutsche Akademie der Naurforscher Leopoldin; 1999. Auto-Immunity: Altman, Amnon (ed.) . Signal transducation pathways in autoimmunity. Basel: Karger; 2002. Bastenie, P. A. (ed.) & Gept, W. (ed.) & Addison, G. M. (ed.) . Immunity and autoimmunity in diabetes mellitus ; proceedings of the francqui foundation colloquium, ; brussels, april 30- may 1, 1973.
    [Show full text]
  • Medical Physics Expert for the Particle Therapy Interuniversity Center Leuven (Particle)
    Medical physics expert for the Particle Therapy Interuniversity Center Leuven (ParTICLe) Leuven (Belgium) Reference: 19000079 Apply before: 21-07-2019 Context A consortium of UZ Leuven/KU Leuven and Cliniques Universitaires Saint- Luc/UCL, strongly supported by UZ Ghent, UZA and UZ Brussels, decided to join forces to build the first proton therapy centre in Belgium, within the context of a solid medical, scientific and strategic alliance with all interested centres and partners. This interuniversity, multi-institutional collaboration is called ParTICLe, i.e. Particle Therapy Interuniversitary Centre Leuven. ParTICLe is currently being built on the Health Sciences Campus Gasthuisberg of the University Hospitals Leuven (UZ Leuven) and will treat its first patients mid-2019 (www.particle.be). An IBA ProteusONE proton therapy system is being installed and will be equipped with the latest features for pencil beam scanning proton therapy, on-board imaging and in-room CT-on-rails for image guidance. After the ramp-up phase of this facility it will be tightly integrated in the clinical practice of the radiation oncology departments of both UZ Leuven and Cliniques Universitaires Saint-Luc (St-Luc Hospital). The department of Radiation Oncology at UZ Leuven is equipped with five external beam radiotherapy treatment units, comprising two Varian Halcyon systems, two Varian TrueBeam systems and a Varian/BrainLab TrueBeam STX system. For treatment simulation, two high-end large bore CT’s are used. Complex techniques such as VMAT/IMRT, advanced IGRT, SBRT and SRS are used as part of the daily clinical routine. Brachytherapy is also an important element of the treatments offered, using PDR and HDR techniques as well as Ruthenium-106 for ocular malignancies.
    [Show full text]
  • Fourth Joint LWPESJESPE Meeting 1993 Final Program
    003 1-399819313305-0000$03.00/0 Vol. 33, No. 5, 1993 PEDIATRIC RESEARCH Printed in U.S.A. Copyright O 1993 International Pediatric Research Foundation, Inc. Fourth Joint LWPESJESPE Meeting 1993 Final Program FRIDAY, JUNE 4,1993 MORNING 9. Hormonal Monitoring and Side Effects of 8: 15 Opening ceremony Prenatal Dexamethasone Treatment for 21 - Fairmont Grand Ballroom Hydroxylase Deficiency Congenital Adrenal Melvin M. Grumbach, Chairman, Hyperplasia Organizing Committee SongyaPang Jo Anne Brasel, President, LWPES Department of Pediatrics Ieuan A. Hughes, President, ESPE University of Illinois College of Medicine, Chicago, IL PLENARY SESSION, I Fairmont Grand Ballroom 10. Prenatal Treatment of Congenital Adrenal 8:30 1. Lawson Wilkins Lecture: Hyperplasia Due to 21 -Hydroxylase Diabetes Mellitus, Type I - Islet Cell Deficiency: European Experience in 223 Destruction and Growth Studied in Pregnancies at Risk Transgenic Animal Models M. G. Forest Nora Sarvetnick I.N.S.E.R.M., Hopital Debrousse, Lyon, Department of Neuropharmacology France Scripps Research Institute, and LaJolla, CA H. G. Dorr Klinik fur Kinder and Jugendliche, 9:30 BREAK University Erlangen-Nurnberg, Erlangen, Germany CONCURRENT SYMPOSIA, I 11. Prenatal Treatment of Congenital Adrenal 10:OO-11:30 A.M. Hyperplasia SESSION A: Prenatal Diagnosis and P. Speiser Treatment of CAH Department of Pediatrics Fairmont Grand Ballroom The New York Hospital 10:OO 7. Molecular Pathology of 21 -Hydroxylase Cornell Medical Center, Deficiency New York, NY Tom Strachan Division of Human Genetics SESSION B: IDDM - Pharmacologic and University of Newcastle upon Tyne, UK Transplant Approaches to Therapy 10:20 8. Prenatal Diagnosis of Congenital Adrenal Mark Hopkins Peacock Court Hyperplasia Due to 21 -Hydroxylase 10:OO 12.
    [Show full text]